Initially, GLP-1s were developed to treat type 2 diabetes and were marketed for that purpose under brand names such as Ozempic (semaglutide), Rybelsus (semaglutide), Victoza (liraglutide), and Mounjaro (tirzepatide)
For one project, Cohen tried to disrupt a protein associated with insulin resistance and diabetes
Final Safety Disclaimer Final Safety Disclaimer The content on this page is provided for informational and educational purposes only and should not be interpreted as medical advice, diagnosis, or treatment
Increasing awareness about Jascayd is vital to encourage early diagnosis and timely treatment intervention in IPF, ultimately impacting patients lives positively
Supplements and Therapies: If needed, consult a healthcare professional to determine the best approach to supplementation, which may include oral supplements or intravenous therapy
The effects may vary with each individual, depending on the specific peptide therapy being administered, the health issue being addressed, and its severity